AR120118A2 - ANTI-TIGIT ANTIBODIES - Google Patents
ANTI-TIGIT ANTIBODIESInfo
- Publication number
- AR120118A2 AR120118A2 ARP200102706A ARP200102706A AR120118A2 AR 120118 A2 AR120118 A2 AR 120118A2 AR P200102706 A ARP200102706 A AR P200102706A AR P200102706 A ARP200102706 A AR P200102706A AR 120118 A2 AR120118 A2 AR 120118A2
- Authority
- AR
- Argentina
- Prior art keywords
- tigit antibodies
- antibodies
- tigit
- cancer
- diseases
- Prior art date
Links
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente se refiere a anticuerpos anti TIGIT, así como al uso de estos anticuerpos en el tratamiento de enfermedades tales como cáncer y enfermedad infecciosa.This relates to anti-TIGIT antibodies, as well as the use of these antibodies in the treatment of diseases such as cancer and infectious disease.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462038912P | 2014-08-19 | 2014-08-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR120118A2 true AR120118A2 (en) | 2022-02-02 |
Family
ID=58694403
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP150102630A AR101565A1 (en) | 2014-08-19 | 2015-08-14 | ANTI TIGIT ANTIBODIES |
| ARP200102706A AR120118A2 (en) | 2014-08-19 | 2020-09-29 | ANTI-TIGIT ANTIBODIES |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP150102630A AR101565A1 (en) | 2014-08-19 | 2015-08-14 | ANTI TIGIT ANTIBODIES |
Country Status (2)
| Country | Link |
|---|---|
| AR (2) | AR101565A1 (en) |
| EC (1) | ECSP17016755A (en) |
-
2015
- 2015-08-14 AR ARP150102630A patent/AR101565A1/en active IP Right Grant
-
2017
- 2017-03-17 EC ECIEPI201716755A patent/ECSP17016755A/en unknown
-
2020
- 2020-09-29 AR ARP200102706A patent/AR120118A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR101565A1 (en) | 2016-12-28 |
| ECSP17016755A (en) | 2017-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2017001561A2 (en) | Anti tigit antibodies | |
| ECSP19020740A (en) | ANTI-CD27 ANTIBODIES | |
| MX2023014569A (en) | ANTI-SIRPA ANTIBODIES. | |
| MX2017006283A (en) | USEFUL MACROCICLIC PEPTIDES AS IMMUNOMODULATORS. | |
| CL2016002455A1 (en) | Multispecific antibodies. | |
| CO2017007121A2 (en) | Fused bicyclic compounds for the treatment of diseases | |
| CL2017000053A1 (en) | Β-protofibril binding antibodies | |
| EA201590503A1 (en) | ALPHA-1-Microglobulin for use in the treatment of diseases associated with mitochondria | |
| AR120118A2 (en) | ANTI-TIGIT ANTIBODIES | |
| AR111715A1 (en) | ANTI-SIRPa ANTIBODIES | |
| EA202091619A3 (en) | ANTIBODIES AGAINST TIGIT | |
| MX2016013947A (en) | USE OF THE OXYMATE OF THE ACETATE OF THE 23 (S) -ACETILDIOSGENINE AS ANTICHANCERIGEN IN CANCER CERVICOUTERINO. | |
| UA104459U (en) | The use of lactoproteinum with sorbitol as tsytoprotektora adenohypophysis at burn disease. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |